Breast Cancer

Feb. 27, 2020, 9:53 AM by Bill Snyder Researchers at Vanderbilt University Medical Center are reporting another advance in the understanding and treatment of triple-negative breast cancer, which is particularly aggressive and difficult to treat. Their findings, detailed in the journal Clinical Cancer Research, offer new hope for identifying… Read More

Aug. 22, 2019, 9:29 AM  by Tom Wilemon Breast cancer researchers at Vanderbilt-Ingram Cancer Center (VICC) have secured a fourth round of continuous Specialized Program of Research Excellence funding. The SPORE in Breast Cancer grant from the National Cancer Institute (NCI) is for a five-year period totaling $11.6 million. Applications… Read More

Dec. 13, 2018, 10:00 AM by Leigh MacMillan Immune checkpoint inhibitors — cancer therapies that remove the “brakes” on the adaptive anti-tumor immune response — have had remarkable success in melanoma and lung cancer. Response rates to these immunotherapies in breast cancer have been disappointing, perhaps because breast cancers are… Read More

Promoting Immune-Mediated Therapy in Breast Cancer Image courtesy of Dr. Steven Harmes. Baylor University Medical Center, Dallas Texas. Despite major progress in early diagnosis and treatment, breast cancer (BC) remains the second leading cause of cancer deaths among women in the U.S. A promising new approach to cancer therapy… Read More

Despite major strides in the early detection and treatment of breast cancer, metastatic disease remains a therapeutic challenge, resulting in over 40,000 deaths per year in the United States. Most breast cancers are the result of genetic mutations that lead to abnormal growth and invasive behavior of the tumor cells. Read More